ArticleFrontiers in immunology2025

Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy.

Zhouwei Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.